Rational questing for inhibitors of endothelin converting enzyme-1 from Salvia miltiorrhiza by combining ligand- and structure-based virtual screening

Abstract

In this study, a virtual screening approach based on pharmacophore and molecular docking was proposed to identify endothelin converting enzyme-1 (ECE-1) (EC 3.4.24.71) inhibitors from Salvia miltiorrhiza. First, the pharmacophore models were generated to recognize the common features of the ECE-1 inhibitors. The models were validated by a test database composed by a set of compounds known as ECE-1 inhibitors and nonactive compounds and proven to be successful in discriminating active and inactive inhibitors. Then, the best pharmacophore model was used to screen the compounds from S. miltiorrhiza. Furthermore, the Surflex-Dock procedure was used for molecular docking. All compounds from S. miltiorrhiza were docked into the active site of the target protein. An empirical scoring function was used to evaluate the affinity of the compounds and the target protein. Comparing the virtual screening results based on pharmacophore and molecular docking, respectively, 11 communal compounds with higher QFIT and docking score were hit, and the activity of some compounds was validated in the literature. The binding modes between these compounds and the ECE-1 binding site were predicted and used to identify the key interactions that contribute to the inhibitory activity of ECE-1 activity. The results show that the two methods have good consistency and can be validated and supplemented with each other.

Discovery of Dual ETA/ETB Receptor Antagonists from Traditional Chinese Herbs through in Silico and in Vitro Screening

“…Four parameters ( i.e. , A%, Y%, N and CAI) proposed in our previous work [ 55 ] were calculated to evaluate the performance of the models. D is the number of compounds in the external database while A is the number of active compounds.…”

The Mechanism Research of Qishen Yiqi Formula by Module-Network Analysis

“…The targets' information of main active components of QSYQ was obtained from two parts: pharmacophore virtual screening and the component-protein interaction database including ChEMBL ( https://www.ebi.ac.uk/chembl/# ) [ 11 ] and STITCH 3.1 ( http://stitch.embl.de/ ) [ 12 ]. The 27 pharmacophore models which were applied to virtual screen were constructed by our laboratory team [ 13 , 14 ]. ChEMBL is a manually curated chemical database which contains compound bioactivity data against drug targets.…”

The rational search for PDE10A inhibitors from Sophora�flavescens roots using pharmacophore‑ and docking‑based virtual screening

“…N indicates the ability to recognize the known PDE10A inhibitors compared with non-PDE10A inhibiting compounds. CAI expresses the comprehensive ability to discover PDE10A inhibitors from a specific database (28).…”